Skip to main content

Month: April 2025

GPTBots Showcases Cutting-Edge Enterprise AI Solutions at The MarTech Summit Asia 2025

HONG KONG, April 10, 2025 (GLOBE NEWSWIRE) — GPTBots.ai, a leading enterprise AI agent platform, proudly showcased its cutting-edge AI solutions at The MarTech Summit Asia 2025, held in Singapore. The event brought together senior executives and decision-makers from diverse industries, all seeking innovative technologies to address their unique business challenges. GPTBots stood out as a trusted partner, offering tailored AI applications that empower enterprises to streamline operations, enhance customer experiences, and drive growth. 1. Enterprise Challenges, Tailored AI SolutionsAt the summit, GPTBots engaged with senior leaders from some of the most prominent organizations in the region, each presenting specific challenges that required advanced, customized AI solutions. The discussions highlighted a key trend: off-the-shelf...

Continue reading

Li Auto Inc. Releases 2024 Environmental, Social and Governance Report

BEIJING, China, April 10, 2025 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today released its 2024 Environmental, Social and Governance (ESG) report. The report details the Company’s ongoing efforts to integrate sustainability into its corporate strategies and operations, highlighting measurable advancements across its sustainability initiatives. Li Auto has made significant progress in advancing its longstanding sustainability objectives through a continued focus on operational compliance and corporate governance, innovation and product excellence, low-carbon operations, employee well-being, and community engagement. As the Company continues to pursue its vision and mission, it remains committed to positively impacting the environment and...

Continue reading

Curium strengthens its PET manufacturing capacity and expands European footprint with the acquisition of Nucleis

The acquisition of Nucleis will:Enhance Curium’s PET manufacturing capacity and radiopharmaceutical distribution network of 32 PET sites in Western Europe Improve reliability and accessibility of life-saving PET diagnostics for patients in Benelux and Germany Expand CDMO capabilities to support the development of innovative PET tracers in oncology, neurology, and cardiologyPARIS, April 10, 2025 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced today that it has completed the acquisition of Nucleis, a specialist in GMP manufacturing and distribution of PET radiopharmaceutical drugs. Founded in 2017 as a spin-off from the University of Liège (Cyclotron Research Center, Belgium), Nucleis has established itself as a key player in PET imaging radiopharmaceuticals. Nucleis manufactures and distributes FDG in...

Continue reading

Ársreikningur Hafnarfjarðarkaupstaðar fyrir árið 2024

Gott rekstrarár að baki hjá Hafnarfjarðarbæ og fjárhagsstaðan traust Ársreikningur Hafnarfjarðarbæjar fyrir árið 2024 var lagður fram í bæjarráði í dag 10. apríl 2025. Rekstrarafgangur fyrir A og B hluta nam 1.208 milljónum króna á árinu 2024, samanborið við 808 milljónir árið áður. Rekstrarniðurstaða fyrir fjármagnsliði nam 3.545 milljónum króna. Afgangur af rekstri A hluta nam 117 milljón króna 2024 en var 251 milljón króna árið á undan. Veltufé frá rekstri A og B hluta nam 3.734 milljónum króna og var 975 milljónum yfir áætlun. Veltufé frá rekstri svaraði til 7,6% af heildartekjum en það var 5,6% af heildartekjum árið á undan. Skuldaviðmið samstæðu Hafnarfjarðarbæjar nam 90% í árslok 2024.  ,,Grunnrekstur Hafnarfjarðarbæjar gekk mjög vel á síðasta ári þrátt fyrir heldur minni fjölgun íbúa en gert var ráð fyrir og hægari uppbyggingu...

Continue reading

Results of the Annual General Meeting in Svitzer Group A/S

The Annual General Meeting of Svitzer Group A/S took place on 10 April 2025 as a completely electronic general meeting with the agenda set out below. The Board of Directors had appointed Niels Kornerup, attorney-at-law, as meeting chair. AgendaThe Board of Directors’ report on the Company’s activities in the past financial yearThe general meeting took notice of the Chair of the Board of Directors’ report on the Company’s activities in the past financial year.Presentation and adoption of the audited annual reportThe audited annual report was presented and adopted.Distribution of profit or covering of loss according to the adopted annual reportThe general meeting resolved to distribute a dividend of DKK 8.00 per share with a nominal value of DKK 10.00each and that the remaining result for 2024 was carried forward to next year.Resolution...

Continue reading

Spin-Out of ASC Energy from Global Interconnection Group

The Board of Global Interconnection Group Limited (GIG) is pleased to confirm that the independent directors resolved on the 9th April 2025 to spin out Atlantic SuperConnection (ASC Energy) from GIG. This represents a necessary step towards raising substantial funding to progress ASC Energy to Final Investment Decision (FID) and beyond. Please see the full press release attached. AttachmentSpinOut of Atlantic SuperConnection

Continue reading

Share Buyback Transaction Details April 3 – April 9, 2025

 PRESS RELEASE                                         Share Buyback Transaction Details April 3 – April 9, 2025 Alphen aan den Rijn – April 10, 2025 – Wolters Kluwer (Euronext: WKL), a global leader in professional information, software solutions, and services, today reports that it has repurchased 124,929 of its own ordinary shares in the period from April 3, 2025, up to and including April 9, 2025, for €17.5 million and at an average share price of €140.42. These repurchases are part of the share buyback program announced on February 26, 2025, under which we intend to repurchase shares for up to € 1 billion during 2025. The cumulative amounts repurchased in the year to date under this program are as follows: Share Buyback 2025Period Cumulative shares repurchased in period Total consideration(€ million) Average share...

Continue reading

WisdomTree Multi Asset Issuer PLC (the “Issuer”) Restrike of WisdomTree NASDAQ 100 5x Daily Short (the “Impacted Product”)

WisdomTree Multi Asset Issuer PLC LEI: 2138003QW2ZAYZODBU2310 April 2025 WisdomTree Multi Asset Issuer PLC(the “Issuer”)Restrike of WisdomTree NASDAQ 100 5x Daily Short (the “Impacted Product”) The Issuer announces that due to movements in NASDAQ 100 Futures contract prices referenced by the US Technology Rolling Futures ER Index, a Restrike Event has occurred with respect to the Impacted Product. The details of the restrike are as follows:Start of Restrike Period: 19:00:07 (London time) on 9 April 2025 End of Restrike Period: 19:15:07 (London time) on 9 April 2025 Restrike Price per ETP Security: $7.2242993 Restrike threshold: 10% Index: US Technology Rolling Futures ER IndexThe Restrike Price Per ETP Security has been calculated based on the Restrike Index Level. The Restrike Index Level has been calculated based on the above value...

Continue reading

WTW unveils next phase in rollout of its Neuron digital trading platform

Liberty Specialty Markets to use Neuron to undertake live trading of D&O and Cyber risks. LONDON, April 10, 2025 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, has today announced that Liberty Specialty Markets (LSM) is now using Neuron, WTW’s digital trading solution, to undertake live trading of Directors & Officers (D&O) and Cyber risks. LSM capacity became available on Neuron on 31 March 2025. While initially accessible across two open market business classes, Cyber and D&O, the addition of LSM’s capacity aligns with Neuron’s broader expansion, which includes increasing follow capacity with additional classes and partners to be confirmed through 2025. Neuron connects brokers and insurers in real time, simplifying and accelerating the trading of complex specialty...

Continue reading

Treatment.com AI Closes Previously Announced Acquisition of Rocket Doctor Inc.

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 10, 2025 (GLOBE NEWSWIRE) — Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce, further to its news release of February 12, 2025, that it has closed the acquisition of 100% of the issued and outstanding securities of Rocket Doctor Inc. (the “Transaction”) pursuant to the terms and conditions of a Share Purchase Agreement dated February 11, 2025, as amended (the “Definitive Agreement”) with Rocket Doctor Inc. (“Rocket Doctor”) and the common shareholders of Rocket Doctor. Rocket Doctor is a Canadian federally incorporated company with a US Delaware subsidiary, which aims to transform the way healthcare is delivered, through empowering doctors...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.